PURCHASE ORDER
Active75F40126P00169
Department of Health and Human Services › Food and Drug Administration › FDA OFFICE OF ACQ GRANT SVCS
$164.9K
obligated · signed 1 month ago
EO 14398
Performance timeline
Start
Aug 25, 2026
Current end
Aug 24, 2027
Potential end
Feb 24, 2028
with all options
Loading status
Estimated start: Feb 24, 2027
GEORGIA TECH RESEARCH CORP
Contract 75F40126P00169
UEI
EMW9FC8J3HN4
Parent Company
UNIVERSITY SYSTEM OF GEORGIA
Capabilities & Certifications
Headquarters Location
Congressional District: 05
Current Obligation
$164,930
Base + Exercised Options
$164,930
Total Ceiling Value
$252,330
Contract Type
FIRM FIXED PRICE
NAICS
RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
PSC
SPECIAL STUDIES/ANALYSIS- SCIENTIFIC DATA
Place of Performance
Congressional District: 04
Awarding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Funding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Solicitation procedures, competition exceptions, labor standards and account totals.